BioCentury
ARTICLE | Product Development

Diamonds in a rough 2023, predictions for 2024

BioCentury’s analysts look back at a year when innovation was hot but markets were not, and predict what’ll make news in 2024

December 21, 2023 1:51 AM UTC

2023 — a year in which the gloom of the capital markets was matched by a boom in innovation. This was an unequivocally terrible year for finance, and a relatively bad one for the industry on the public policy front. But it was an excellent year for proof of principle that the biopharma industry can take concepts from lab to patient, and produce groundbreaking treatments with societal impact. Moreover, it didn’t take a pandemic to demonstrate that. 

BioCentury’s analysts give you their top picks of 2023, sorted by topic, and then tell you what to watch for in 2024. ...